Abstract
The differential distribution of natriuretic peptide receptor subtypes and their distinct properties were assessed in mammalian cellular models which were screened for their ability to produce cGMP upon stimulation by different natriuretic peptides. The ANF-R1A receptor subtype was distinguished by its selective activation by atrial natriuretic factor (ANF) while the ANF-R1C was characterized by preferential stimulation by C-type natriuretic peptide (CNP). AT-t20 pituitary cells, bovine adrenal chromaffin cells, and NIH-3T3 fibroblasts mainly express the ANF-R1C receptor subtype. Other cell lines such as PC12, RASM and GH3 express significant but varying amounts of both ANF-R1A and ANF-R1C subtypes. A10 and NIH cells which express high density of ANF-R2 receptor subtype, also demonstrate a higher sensitivity to CNP over ANF suggesting that they express significant amounts of ANF-R1C. Studies of the regulation by ATP of guanylyl cyclase activity indicate that both ANF-R1A and ANF-R1C subtypes are modulated in the same manner. In the presence of Mn2+, ATP inhibits the CNP-stimulated guanylyl cyclase activity while in the presence of Mg2+ adenine nucleotides potentiate the stimulation by CNP. In addition, we show that like the ANF-R1A, the ANF-R1C guanylyl cyclase activity can be regulated by phosphorylation since preincubation with TPA or FKL attenuates the subsequent stimulation by CNP in cultured cells. The results presented demonstrate that specific cell types express distinct natriuretic peptide receptor subtypes and also that the newly characterized ANF-R1C subtype is regulated by ATP and serine/threonine kinases in the same way as the ANF-R1A subtype.
Similar content being viewed by others
Abbreviations
- ANF:
-
atrial natriuretic factor
- BNP:
-
brain natriuretic peptide
- CNP:
-
C-type natriuretic peptide
- ATP:
-
adenosine-5′-triphosphate
- IBMX:
-
3-isobutyl-1-methylxanthine
- TPA:
-
12-O-tetradecanoyl-phorbol-13-acetate
- FKL:
-
forskolin
- PKC:
-
calcium-phospholipid-dependent protein kinase
- PKA:
-
cAMP-dependent protein kinase
- PKG:
-
cGMP-dependent protein kinase
- C-ANF:
-
[Cys116]-ANF-(102-116)-NH2
- CC:
-
chromaffin cells
References
Féthière J, De Léan A: Pharmacological evidence for the heterogeneity of atrial natriuretic factor-R1 receptor subtype. Mol Pharmacol 40:915–922, 1991
Koller KJ, Lowe DG, Bennett GL, Minamino N, Kangawa K, Matsuo H, Goeddel DV: Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 252:120–123 1991
Féthière J, Graihle R, De Léan A: Identification of the ANF-R1C (B-Clone) receptor subtype in culture rat aortic smooth muscle cells. FEBS Letters 305:77–80, 1992
Féthière J, Meloche S, Nguyen T-T, Ong H, De Léan A: Distinct properties of atrial natriuretic factor receptor subpopulations in epithelial and fibroblast cell lines. Mol Pharmacol 35:584–592, 1989
Anand-Srivastava MB, Sairam MR, Cantin M: Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system: Possible coupling of clearance atrial natriuretic factor receptors to adenylate cyclase/cAMP signal transduction system. J Biol Chem 265 (15):8566–8572, 1990
Maack T, Suzuki M, Almeida FA, Nussenzveig D, Scarborough RM, McEnroe GA, Lewicki JA: Physiological role of silent receptors for atrial natriuretic factor. Science 238:675–678, 1987
Singh S, Lowe DG, Thorpe DS, Rodriguez H, Kuang J-W, Dangott LJ, Chinkers M, Goeddel DV, Garbers DL: Membrane guanylyl cyclase is a cell-surface receptor with homology to protein kinases. Nature 334:708–712, 1988
Chang M-S, Lowe DG, Lewis M, Hellmiss R, Chen E, Goeddel DV: Differential activation by atrial natriuretic and brain natriuretic peptides of two different receptor guanylyl cyclases. Nature 341:68–72, 1989
Fuller F, Porter JG, Arfsten AE, Miller J, Schilling JW, Scarborough RM, Lewicki JA, Schenk DB: Atrial natriuretic peptide clearance receptor: Complete sequence and functional expression on cDNA clones. J Biol Chem 263 (19):9395–9401, 1988
Wilcox JN, Augustine A, Goeddel DV, Lowe DG: Differential regional expression of three natriuretic peptide receptor genes within primate tissues. Mol Cell Biol 11 (7):3454–3462, 1991
Kurose H, Inagami T, Ui M: Participation of adenosine 5′-triphosphate in the activation of membrane-bound guanylyl-cyclase by the atrial natriuretic factor. FEBS Letters 219 (2):375–379, 1987
Larose L, Rondeau J-J, Ong H, De Léan A: Phosphorylation of atrial natriuretic factor R1 receptor by serine/threonine kinases: Evidence for receptor regulation. Mol Cell Biochem 115:203–211, 1992
Nguyen T-T, Ong H, De Léan A: Secretion and biosynthesis of atrial natriuretic factor by cultured adrenal chromaffin cells. FEBS Letters 231 (2):393–396, 1988
Sudoh T, Maekawa K, Kojima M, Minamino N, Kaplan J, Matsuo H: Cloning and sequence analysis of cDNA encoding a precursor for human brain antriuretic peptide. Biochem Biophys Res Comm 159 (3):1427–1434, 1989
Heisler S, Morrier E: Bovine adrenal medullary cells contain functional atrial natriuretic peptide receptors. Biochem Biophys Res Comm 150 (2):781–787, 1988
Shigematsu K, Niwa M, Shimomura C, Kamio T, Ozaki M Tsuchiyama H: Different subtypes of atrial natriuretic peptide receptors in human fetal, neonatal and adult adrenal glands. Biomed Res 11 (2):109–115, 1990
Koch B, Boudjada T, Lutz-Bucher B: Characterization of high affinity receptor sites for atrial natriuretic factor in anterior pituitary gland: Evidence for the existence of two receptor forms. Biochem Biophys Res Comm 152 (2):904–909, 1988
Larose L, McNicoll N, Ong H, De Léan A: Allosteric modulation by ATP of the bovine adrenal natriuretic factor R1 receptor functions. Biochemistry 30(37):8990–8995, 1991
Marala RB, Sitaramayya A, Sharma RK: Dual regulation of atrial natriuretic factor-dependent guanylyl cyclase activity by ATP. FEBS Letters 281 (1):73–76, 1991
Jaiswal RK, Jaiswal N, Sharma RK: Negative regulation of atrial natriuretic factor receptor coupled membrane guanylyl cyclase by phorbol ester: Potential protein kinase C regulation of cyclic GMP signal in isolated adrenocortical carcinoma cells of rat. FEBS Letters 227 (1):47–50, 1988
Lowe DG, Chang M-S, Hellmiss R, Ellson C, Singh S, Garbers DL, Goeddel DV: Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction. EMBO J 8 (5):1377–1384, 1989
Chinkers M, Garbers DL, Chang M-S, Lowe DG, Hemin C, Goeddel DV, Schultz S: A membrane form of guanylyl cyclase is an atrial natriuretic peptide receptor. Nature 338:78–83, 1989
Jaiswal RK: Endothelin inhibits the atrial natriuretic factor stimulated cGMP production by activating the protein kinase C in rat aortic smooth muscle cells. Biochem Biophys Res Comm 182 (1): 395–402, 1992
Neuser D, Stasch J-P, Morich FJ: Modulation of atrial natriuretic peptide-induced cGMP accumulation by [Arg8]vasopressin in the cultured renal epithelial cell line, LLC-PK1. Eur J Pharmacol 146: 341–344, 1988
Nambi P, Whitman M, Gessner G, Aiyar N, Crooke ST: Vasopressin-mediated inhibition of atrial natriuretic factor-stimulated cGMP accumulation in an established smooth muscle cell line. Proc Natl Acad Sci USA 83:8492–8495, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Féthière, J., Graihle, R., Larose, L. et al. Distribution and regulation of natriuretic factor-R1C receptor subtypes in mammalian cell lines. Mol Cell Biochem 124, 11–16 (1993). https://doi.org/10.1007/BF01096376
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01096376